1.
Thasneem KM, Sreejith K, Athulnadh B, Maniyan N, Neena CC, Faris PM. SGLT2 Inhibitors: A Noval Therapuetic Agent in the Treatment of Diabetic Kidney Disease. J. Drug Delivery Ther. [Internet]. 2020 Nov. 15 [cited 2026 Jan. 18];10(6):203-6. Available from: https://www.jddtonline.info/index.php/jddt/article/view/4532